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ABSTRACT
Objectives To examine concentrations of perfluoroalkyl 
substances (PFASs) and lifestyle factors that may 
contribute to higher levels of pollutants in never- pregnant 
women of fertile age.
Design Observational cross- sectional study.
Setting Participants were recruited among employees 
and students at Haukeland University Hospital and the 
University of Bergen, Norway.
Participants Healthy, never- pregnant Norwegian women 
(n=158) of fertile age (18–39 years).
Outcomes Concentrations of 20 different PFASs, mercury 
(Hg), lead, cadmium, total, high- density lipoprotein and 
low- density lipoprotein (LDL) cholesterol, in addition to 
self- reported data on dietary intake.
Results Seven PFASs were detected in more than 95% 
of the women. Women aged 30–39 years had higher 
concentrations of sum PFAS compared with younger 
women. Serum PFASs were significantly intercorrelated 
(rho: 0.34–0.98, p<0.001) and six of them were 
significantly correlated to whole blood Hg (rho: 0.21–0.74, 
p<0.01). Fish consumption was the strongest predictor 
for most serum PFASs and for whole blood Hg. Fish 
consumption and serum perfluorooctanesulfonic acid 
(PFOS) concentrations were both positively associated with 
serum total and LDL cholesterol, established risk factors 
for cardiovascular disease.
Conclusions The majority of Norwegian never- pregnant 
women of fertile age had a mixture of seven different 
PFASs and Hg detected in their blood. PFAS concentrations 
were higher in older women and associated with fish 
intake. As the mean age of women at first birth is 
increasing, several factors require further consideration 
including diet, as this may influence the burden of PFAS to 
the next generation.
Trial registration number  ClinicalTrials. gov ID: 
NCT03272022, Unique Protocol ID: 2011/2447, Regional 
Committee for Medical Research Ethics West (2011/2447), 
12 January 2012.
BACKGROUND
Perfluoroalkyl substances (PFASs) are a group 
of synthetic carbon fluorine compounds that 
have been widely used in various consumer 
products for more than 50 years due to their 
water- repelling and stain- repelling features.1 
All people in industrialised countries have 
measureable amounts of PFASs in their 
blood1 and even in remote areas, selected 
PFASs are detectable in humans.2 3
Parity is a strong predictor of PFAS concen-
trations. Women are reported to have lower 
PFAS concentrations with increasing parity, 
implying that the PFAS load is higher in the 
first- born child.4 PFASs pass the placenta and 
accumulate in fetal blood and tissues during 
pregnancy.5 PFASs have endocrine disrupting 
properties and negative effect on the immune 
system and neurodevelopment.1 In adults, 
dyslipidaemia, with elevated total cholesterol 
and low- density lipoprotein (LDL) choles-
terol, or reduced high- density lipoprotein 
(HDL) cholesterol, is considered the stron-
gest metabolic effect of PFAS exposure.1
Many PFASs are environmentally persistent 
and accumulate in the food chain.1 6 The 
European Food Safety Authority (EFSA) has 
recently estimated that fish and other seafood 
account for up to 86% of dietary PFAS expo-
sure in adults.7 Fish is an important source 
of nutrients; however, due to environmental 
contamination, fish intake is associated with 
a mixture of pollutants,8 including dioxins 
and dioxin- like polychlorinated biphenyls 
What this paper adds
 ► In non- pregnant women aged 18–39 years, older 
women (30–39 years) had higher concentrations of 
sum PFAS as compared to young women.
 ► The most common choice for fish dinner was farmed 
salmon, and fish consumption was the strongest 
predictor for most serum PFASs.
 ► Fish consumption and serum PFOS concentrations 
were both positively associated with serum total and 
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(PCBs),9 and mercury (Hg),10 substances with established 
negative health effects.1 11 12
PFAS concentrations are demonstrated to be higher 
in older individuals,13 and as the mean age of women at 
first birth is getting higher in the Western world,14 this 
may increase the burden of toxic substances in newborns. 
In order to reduce the transfer of pollutants to the next 
generation, it is important to know the PFAS status and 
the risk factors that contribute to higher concentrations 
in the fertile population, particularly in first time mothers.
The aim of the present study was to measure serum 
concentrations of 20 PFASs in healthy, never- pregnant 
Norwegian women of fertile age (18–39 years) and inves-
tigate factors associated with a higher burden of pollut-
ants and effect on lipid status. We have included formerly 
published data on total Hg, lead (Pb) and cadmium 
(Cd)10 to look for correlations that might indicate 
common sources of exposure.
METHODS
Study population and design
Between June 2012 and March 2015, 158 healthy, never- 
pregnant women aged 18–39 years were recruited among 
employees and students at Haukeland University Hospital 
and the University of Bergen, Norway.
Patient and public involvement
No patients were involved in the design and recruitment 
of the study.
Health assessment questionnaire
The women completed a simple, non- validated, question-
naire concerning age, body weight, health status, years 
of completed education, diet, including intake of fish 
for dinner, and the use of micronutrient supplements, 
alcohol and tobacco. The women were categorised as 
‘healthy’ and eligible for inclusion if they reported to 
never have been pregnant and had no chronic illness 
except for well- regulated hypothyroidism and no regular 
use of medications except for thyroxin medication. Fish 
for dinner was categorised as never, <1 times/month, 
1–3 times/month, 1–2 times/week and 3–5 times/week. 
Regular use of micronutrient supplements was defined 
as use more than 3 days per week and the definition of 
a regular tobacco user was based on a plasma cotinine 
concentration >85 nmol/L.15
Blood sampling and analysis
Non- fasting blood samples, obtained by antecubital veni-
puncture and collected into vacutainer tubes without 
additives (Terumo), were collected from morning to 
early afternoon in the period from 2012 to 2015. Serum 
was transferred into Sarstedt tubes without additives with 
plastic pipettes, and stored at − 80°C. For analysis of PFAS, 
the samples were shipped to the University Hospital of 
North Norway (Tromsø, Norway) and were stored at 
−30°C between 1 and 4 years prior to analysis in 2016. 
PFASs are reported to be stable in human serum even in 
room temperature for several months.16 The sampling 
equipment underwent testing for background contami-
nation, which was not present.
Twenty different PFASs were analysed according to 
Huber and Brox17 by an automated fully validated high- 
throughput sample preparation method and analysis 
by ultrahigh pressure liquid chromatography triple- 
quadrupole mass- spectrometry (LC- MS/MS, Waters, 
Milford, Massachusetts, USA). Analysed PFASs consist 
of perfluorobutanoate (PFBA), perfluoropentanoate 
(PFPA), perfluorohexanoate (PFHxA), perfluorohepta-
noate (PFHpA), perfluorooctanoic acid (PFOA), perflu-
orononanoate (PFNA), perfluorodecanoate (PFDA), 
perfluoroundecanoate (PFUnDA), perfluorododeca-
noate (PFDoDA), perfluorotridecanoate (PFTrDA) and 
perfluorotetradecanoate (PFTeDA), perfluorobutane 
sulfonate (PFBS), perfluoropentane sulfonate (PFPS), 
perfluorohexane sulfonate (PFHxS), perfluoroheptane 
sulfonate (PFHpS) and perfluorooctanesulfonic acid 
(PFOS), perfluorononane sulfonate (PFNS), perfluoro-
decane sulfonate (PFDS), perfluorododecane sulfonate 
(PFDoDS) and perfluorooctane sulfonamide (PFOSA). 
Linear species (lin) and sum of linear and branched 
species (sum) were quantified for PFHxS, PFHpS and 
PFOS, while sum of perfluorocarboxylic acids (PFCAs), 
sum of perfluorosulfonic acids (PFSA) and sum of all 
quantified perfluoroalkyl substances (PFAS=PFCA+PFSA) 
were calculated. PFBA and PFPA were not further taken 
into account in the present study since a specific identifi-
cation was not possible without applying a complementary 
analysis method.17 For quality assurance, 4 blank samples, 
4 SRM 1958 (NIST, Gaithersburg, Maryland, USA) and 4 
SRM 1957 (NIST) samples and 3 bovine serum samples 
(Sigma Aldrich, Steinheim, Germany) were analysed 
within each batch of 96 samples to control for background 
and carry- over effects. All the quality controls were within 
the acceptance limits. Analytical coefficients of variation 
(CVa) were ≤10% for all the measured PFASs except for 
PFDA and PFUnDA with CVa of 12% and 18%.
Serum total, LDL and HDL cholesterol were analysed 
in the routine clinical laboratory at Haukeland University 
hospital, Bergen, Norway on Roche Cobas c702 (Roche 
Diagnostics, Basel, Switzerland) automated analyzer. CVa 
for total cholesterol was 3%, LDL cholesterol 2.5% and 
for HDL cholesterol 3%.
Plasma levels of cotinine were assayed by  Bevital. no, 
using an LC- MS/MS method with a lower limit of detec-
tion (LOD) of 1 nmol/L.18 Formerly published data 
on whole blood concentrations of Hg, Pb and Cd were 
included.10
Statistical analysis
The results for age and body mass index (BMI) are 
presented as mean and SD. PFAS concentrations were 
not normally distributed, and are presented as median, 
IQR and total range. Mann- Whitney U test was used to 
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for categorical data. Spearman correlation and multiple 
linear regression were used to explore relationships 
between PFAS concentrations and lifestyle factors. Age, 
BMI and fish consumption, factors known to be associated 
with PFAS concentrations, were entered simultaneously 
into the multiple linear regression models. Graphical 
illustrations of the relationships between various PFASs, 
Hg, serum total and LDL cholesterol were obtained by 
generalised additive models.
LODs for the PFAS analyses were set as concentrations 
calculated by the TargetLynx software for each individual 
sample (LODi) and each individual analyte with a signal 
to noise ratio of 3 divided by the related sample amount. 
Where blank contamination was detected (background 
contribution during sample preparation), LOD was 
calculated as an average of the blanks multiplied by three 
times of their SD. If the LOD calculated from the blank 
contamination was higher than the LODi of the sample, 
the LOD calculated based on the blank samples was used. 
Limit of quantification (LOQ) was defined as three times 
the LOD. To reduce possible bias of left censored data 
analyses we have used the actual values between LOQ 
and LOD. PFAS concentrations below the LOD were 
not quantified (in most cases there was only noise visible 
in the chromatogram) and these data were replaced by 
LODi divided by 2.
Statistical analyses were performed only for PFASs with 
detection rate >90%. PFASs with detection rate <90% 
were included in the PFASs sum concentration (ΣPFAS) 
as well as sum PFCAs and sum PFSAs.
The SPSS statistical programme (.V24) and the pack-
ages ‘mgcv’ in R, V.3.3 (The R Foundation for Statis-
tical Computing) were used for the statistical analyses. 




The participants were healthy, young women with 
a mean age of 25 (SD 5), range 18–39 years and a 
median BMI of 21.8 (IQR 20.6, 23.7, range 17.3–35.2). 
More than 90% of the women had ≥12 years of educa-
tion. Reported median use of alcohol was 2 units per 
week (IQR 0.5, 3.8), ranging from 0 to 12 units. Based 
on plasma cotinine levels≥85 nmol/L, 18/158 (11%) 
women were defined as regular tobacco users. Omega 
3 fatty acids were the most commonly used supplement 
and used by 44%, while multivitamin supplements were 
used by 22% of the women. The majority had a varied 
diet, while 31/158 (20%) women reported that they 
never ate meat or fish. Overall, 4% of the women had 
fish for dinner <1 times/month, 22% 1–3 times/month, 
43% 1–2 times/week and 12% 3–5 times/week. Farmed 
salmon was the most frequently used type of fish (71%), 
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Serum PFAS concentrations in never-pregnant women of 
fertile age
Median, IQR and concentration range of the seven most 
frequently detected PFASs, including linear and sum of 
linear and branched species of PFHpS, PFHxS and PFOS, 
and total sum of PFCAs, PFSAs and PFASs, are shown 
in table 1. PFOA, PFNA, PFDA, PFHxS and PFOS were 
detected in serum of all 158 women, while PFUnDA was 
detected 155 women (98%) and PFHpS in 151 women 
(96%). The remaining PFASs were detected in less 
than 70% of the samples: PFHxA (1%), PFHpA (45%), 
PFDoDA (13%), PFTrDA (24%) and PFTeDA (0%), PFBS 
(37%). PFPS, PFNS, PFDS, PFDoDS and PFOSA were all 
below LOD in 100% of the study population.
PFAS concentrations were strongly intercorrelated 
(rho: 0.34–0.98, p<0.001). Significant positive correlation 
to age was seen for PFUnDA (rho=0.20, p=0.01), and sum 
PFOS (rho=0.24, p=0.002), and weaker correlations were 
observed for age and sum PFSA and sum PFAS, (rho >0.17, 
p<0.03). Women aged 31–39 years (n=23) had up to 50% 
higher median concentrations of sum PFOS, sum PFSA 
and sum PFAS compared with younger women (table 2).
No significant correlations were observed between any 
PFAS concentration and BMI or alcohol intake. Plasma 
cotinine concentrations were negatively correlated 
to sum PFOS, sum PFSA and sum PFAS (rho:<−0.16, 
p<0.04). Smokers had slightly lower median lin PFOS 
concentrations 1.73 (IQR 1.31, 3.30 ng/mL, compared 
with non- smokers 2.51 (IQR 1.75, 3.52 ng/mL), p=0.048. 
Smokers (n=18) had lower intake of fish than non- 
smokers (n=140), only 22% of the smokers had fish for 
dinner once or more per week, compared with 59% of 
the non- smokers, p=0.01.
Fish consumption was positively correlated to all inves-
tigated PFASs (rho: 0.18–0.50, p<0.03), except for PFOA, 
lin and sum PFHxS. The same pattern was seen in multiple 
linear regression models, which additionally included age 
and BMI (table 3).
Relations between PFASs and inorganic pollutants
Median (IQR) whole blood Hg was 4.91 (1.70, 8.68) 
nmol/L, whole blood Pb 0.04 (0.03, 0.05) µmol/L and 
whole blood Cd 1.53 (1.15, 2.18) nmol/L, as formerly 
reported.10 Whole blood Hg was detected in 88% of 
the women and was significantly correlated to six of the 
most frequently detected serum PFASs: PFOA (rho: 0.21, 
p=0.01), PFNA (rho: 0.51, p=0.001), PFDA (rho: 0.60, 
p<0.001), PFUnDA (rho: 0.74, p<0.001), sum PFHpS 
(rho: 0.30, p<0.001), sum PFOS (rho: 0.39, p<0.001). 
A graphical illustration of the strongest correlation, 
(between whole blood Hg and PFUnDA), is shown in 
figure 1. Whole blood Hg was also strongly correlated 
to fish consumption (rho: 0.68, p<0.001). No significant 
correlations to individual or sum PFASs were observed for 
whole blood Pb or Cd.
Relations between PFASs and cholesterol
Median (IQR) serum total cholesterol concentration was 
4.3 (3.8, 4.7) mmol/L, LDL cholesterol 2.4 (2.0, 2.9) 
mmol/L and HDL cholesterol 1.8 (1.5, 2.1) mmol/L. 
Significant positive correlations were seen between PFOS 
(lin and sum) and total and LDL cholesterol (rho >0.25, 
p<0.02) (figure 2). No other PFASs correlated signifi-
cantly with total or LDL cholesterol, and no significant 
correlations were seen between individual or sum PFASs 
and HDL cholesterol.
Intake of fish for dinner was positively correlated to 
total cholesterol (rho=0.25, p=0.02) and LDL cholesterol 
(rho=0.20, p=0.06), but not to HDL cholesterol.
PFOS (lin) were the strongest predictor for total and 
LDL cholesterol concentrations in multiple linear regres-
sion models, which additionally included age, BMI and 
fish consumption (table 4).
DISCUSSION
Seven different PFASs were detected in more than 95% of 
healthy Norwegian never- pregnant women. Women aged 
30–39 years had up to 50% higher median concentrations 
of sum PFOS, PFSA and PFAS compared with younger 
women. Six of the PFASs (PFOA, PFNA, PFDA, PFUnDA, 
sum PFHpS and sum PFOS) were significantly correlated 
to whole blood Hg. Fish consumption was the strongest 
predictor for all PFAS concentrations, except for PFOA 
and PFHxS, and for whole blood Hg. Serum PFOS 
concentration and fish consumption were both positively 
associated with total and LDL cholesterol concentrations.
There are more than 4500 different PFASs, but the 
most studied are PFOS and PFOA.1 PFOS was restricted 
according to the Stockholm convention list in 2011, and 
PFOA was included in 2019 (https://www. sciencedirect. 
com/ topics/ earth- and- planetary- sciences/ stockholm- 
convention). The EFSA reduced in 2018 the tolerably 
weekly intake (TWI) of both PFOS and PFOA;19 however, 










4.12 (2.99–5.71) 0.002 4.95 (3.71–6.53) 0.004 7.57 (5.67–9.37) 0.009
31–39 years
N=23
6.18 (4.40–8.39) 6.86 (5.30–9.63) 9.37 (7.54–12.89)
*Values are given as median (IQR) and compared by Mann- Whitney U test.
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according to the EFSA, a considerable proportion of 
the population exceeds the proposed TWIs of both 
compounds.
Several studies have examined PFASs status in the non- 
pregnant women,20 21 including the impact on choles-
terol concentrations.22 A non- pregnant population may, 
however, contain parous women, and as many PFASs are 
transferred from the mother to the fetus and infant during 
pregnancy and breast feeding, respectively, this will influ-
ence PFAS concentrations. In a Norwegian study, preg-
nant parous women had 46% lower PFOS and 70% lower 
PFOA than pregnant, nulliparous women.23 Few studies 
have examined PFAS status in never- pregnant women of 
fertile age. In 2014, Chinese nulliparous women, aged 
20–40 years, had higher median sum PFAS (12.16 ng/
mL), PFOA (5.07 ng/mL), PFNA (0.52 ng/mL) and 
PFDA (0.45 ng/mL), but lower PFOS (4.05 ng/mL) and 
PFHxS (0.24 ng/mL) concentrations, compared with our 
population of Norwegian women.24
The measured PFAS concentrations in the Norwe-
gian women are more or less comparable to the levels 
reported in Norwegian adolescents aged 15–19 years 
from the Artic area.25 All PFASs, except PFOA and 
PFHxS, showed a positive correlation to age, particularly 
PFOS and PFUnDA, which have also been demonstrated 
in other cross- sectional studies.13 23 26 As both inorganic 
and organic pollutants show higher concentrations in 
individuals of higher age,13 older first time mothers may 
transfer a higher amount of pollutants to the child during 
pregnancy and lactation. Advanced maternal age is asso-
ciated with health problems in the offspring, including 






























































































































































































































































































































































































































































































































































































































































































































Figure 1 Serum perfluoroundecanoate (PFUnDA) in relation 
to whole blood mercury (Hg) in never- pregnant women aged 
18–39 years, by generalised additive models. The values on 
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conditions have been related to effects of PFAS1 and 
other persistent organic pollutants.28
Serum concentrations of the various PFASs were 
strongly intercorrelated, and all, but PFHxS, were highly 
correlated to whole blood Hg, particularly PFUnDA and 
Hg. The same pattern was observed in a US population,29 
and most likely reflects a common source of these six 
PFASs and Hg. In our population, fish consumption was 
the strongest determinant of PFAS concentrations and 
strongly correlated with whole blood Hg,10 which are in 
accordance with other published studies.13 23 25 26 30–33
Farmed salmon was reported to be the most common 
choice of fish for dinner and omega 3 fatty acids were 
the most common supplement used by the women. These 
dietary habits reflect current Norwegian recommenda-
tions (https:// helsenorge. no/ kosthold- og- ernaring/ 
kostrad/ spis- fisk- oftere), which is to eat fish for dinner 
two to three times per week. Approximately half of this 
should be fatty fish, known to be rich in omega 3 fatty acids, 
which has been considered to reduce the risk of meta-
bolic syndrome and cardiovascular disease in particular.34 
A recently published 13- year follow- up study suggested, 
however, that lean fish, but not fatty fish consumption, 
seems to be associated with beneficial changes in meta-
bolic syndrome.35 This difference may be related to the 
contamination profile in fatty versus lean fish. Previous 
studies have demonstrated an association between intake 
of fatty fish and fish oil and higher serum concentra-
tions of persistent organic pollutants like PFASs23 and 
dioxins, and dioxin- like PCBs.9 While both organic and 
inorganic pollutants are associated with numerous nega-
tive health effects,1 11 12 it has been advocated that the 
beneficial effects of fish counteract the negative effects 
of these pollutants.36 However, the observed relation 
between PFOS and dyslipidaemia challenges this belief. 
High total and LDL cholesterol are established major 
risk factors for cardiovascular disease,37 and PFOS, found 
to be solely related to intake of seafood,23 is associated 
with higher serum total and LDL cholesterol concentra-
tion.38 The common belief that increasing your intake of 
Figure 2 Serum total and low- density lipoprotein (LDL) 
cholesterol in relation to serum sum PFOS in never- 
pregnant women aged 18–39 years, by generalised 
additive models. The values on the y- axes are given as 
difference from the respective mean values. sum PFOS, sum 
perfluorooctanesulfonic acid.
Table 4 Determinants of serum cholesterol concentrations in never- pregnant women aged 18–39 years by multiple linear 
regression, n=158
Variables included in 
the model
Serum total cholesterol, 
mmol/L
Serum low- density lipoprotein 
cholesterol, mmol/L
Serum high- density lipoprotein 
cholesterol, mmol/L
B* Beta* P value B* Beta* P value B* Beta* P value
Age† 0.02 0.10 0.34 0.01 0.04 0.73 0.01 0.07 0.54
Body mass index 0.03 0.11 0.26 0.05 0.24 0.02 −0.05 −0.30 0.004
Fish consumption‡ 0.07 0.15 0.16 0.04 0.10 0.38 0.05 0.16 0.16
Lin PFOS§ 0.19 0.28 0.01 0.18 0.31 0.004 0.01 0.03 0.77
*B refers to the unstandardised beta and beta to the standardised beta.
†Age in years.
‡Fish consumption categorised; Fish for dinner: Never (20%),<1 times/month (4%), 1–3 times/month (22%), 1–2 times/week (43%) and 3–5 
times/week (12%).
§Lin PFOS, continuous serum concentrations.
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marine omega 3 fatty acids by consuming more fatty fish 
and fish oil supplements reduces the risk of heart disease, 
stroke and death, have repeatedly been questioned,39 
and a recent Cochrane review concluded that increasing 
the intake of omega 3 fatty acids has little or no effect 
on mortality or cardiovascular health40 and should not be 
recommended.41 Fish is an important nutrient, but the 
contamination of fish and seafood must be taken into 
consideration when giving dietary advice, particular for 
vulnerable groups, such as children and women of fertile 
age.42
Fish, and particularly fatty fish is an important source 
of vitamin D, and vitamin D deficiency is reported to be a 
problem when UV- B radiation is sparse.43 If fish consump-
tion is reduced, alternative food sources of vitamin D, 
such as egg, cheese, fortified foods or supplements need 
to be included in the diet, particularly during wintertime 
in high latitudes.44
We did not find any significant correlations between 
PFASs and BMI. Apart for a significant correlation 
between PFHxS and BMI in Norwegian pregnant women, 
no correlation between PFASs and BMI have been 
reported in other studies.23 Higher PFOA concentrations 
have been reported in smokers,23 and positive associa-
tions between PFOA, PFNA and PFDA sum PFHxS and 
sum PFAS are reported in chewed tobacco users.25 Inter-
estingly, smokers in our population had lower lin PFOS 
concentrations, a finding which have been reported 
before.23 45 We have formerly reported that smoking 
women of fertile age also have lower Hg concentrations.10 
These associations may be explained by different life-
style patterns in smokers versus non- smokers. Smokers 
consumed less fish and their level of PFOS and Hg, which 
are both related to fish intake,10 23 are, therefore, lower. 
Eating fish is considered to be part of a healthy lifestyle, 
while smoking is not. Intake of seafood has in fact, been 
suggested as a proxy for a healthy lifestyle,46 something 
which may contribute to an overestimation of the positive 
health effects related to fish intake.
This was a cross- sectional, observational study with 
a small sample size, which represent a limitation to the 
study. The dietary data were self- reported and the cross- 
sectional nature of the data does not permit conclusions 
about causality of the associations. Our study describes 
PFAS status in Norwegian never- pregnant women between 
June 2012 and March 2015, and is not representative 
for PFAS status in other populations or in other time 
periods. Unmeasured confounding variables and tempo-
rality issues are a problem in drawing causal inferences 
in observational studies. As exposure and outcome were 
measured at the same time, any correlation may reflect 
mutual dependence on some unknown, time- related 
variable.
CONCLUSION
The majority of Norwegian never- pregnant women of 
fertile age had a mixture of seven different PFASs and 
Hg detected in their blood. PFASs concentrations were 
higher in older women and associated with fish intake. 
As the mean age of women at first birth is increasing, 
several factors require further consideration including 
diet, as this may influence the burden of PFAS to the next 
generation.
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